Ahmed S. Shehab
Alexandria, 21431, Egypt
NCT Number: NCT05907993
The aim of this study will be to evaluate the effectiveness of intravenous ibuprofen versus intravenous ketorolac for postoperative pain relief after caesarian section
1. The Primary outcome is measurement of visual analogue score during rest and movement 2. The Secondary outcome is measurement of 24 hours opioids requirements.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Phase 4
Alexandria, 21431, Egypt
METHODS
All parturients included in the study will be assessed thoroughly by:
Using a multichannel monitor (mindary) iMeC12 SHENZEN MINDRAY BIO-MEDICAL ELECTRONICS CO, LTD, CHINA, the parturients will be continuously monitored for:
MEASUREMENTS
The following parameters will be measured for all parturients, in both groups:
Age (years) Body Mass index ( kilogram/meters2) Weight (kilograms) Height (meters) Duration of surgery (minutes)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intravenous Ibuprofen versus intravenous Ketorolac for postoperative pain relief
Time frame: after the surgery average 24 hours postoperative
measurement of visual analogue score during rest and movement . The Score range from 0- 10 . 0 means no pain and 10 indicates the worst pain ever
Time frame: after the surgery average 24 hours postoperative
Total opioid cumulative requirement dose
Alexandria University
Other
The Effectiveness Of Intravenous Ibuprofen Versus Intravenous Ketorolac For Postoperative Pain Relief After Cesarean Section
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02210429
Acute Pain, Neurologic Manifestations
Chicago, Illinois, United States
View Trial DetailsNCT04820400
Agnosia, Burns
Toronto, Canada
View Trial DetailsNCT06498713
Agnosia, Nervous System Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT07744503
Arthritis, Arthroplasty, Replacement, Knee
Klagenfurt, Carinthia, Austria
View Trial Details